Transpek Industry Limited disclosed its unaudited financial results for the quarter ended June 30, 2026, following approval by the Board of Directors at a meeting held on August 7, 2026. The results were previously reviewed by the Audit Committee on the same day. The meeting commenced at 2:00 PM and concluded at an unspecified time.

Financial Performance (Standalone - Quarter Ended June 30, 2026)

  • Total Income: ₹15,506.35 lakh (comprising Revenue from Operations: ₹15,106.27 lakh and Other Income: ₹400.08 lakh)
  • Total Expenses: ₹14,327.48 lakh
  • Cost of Materials Consumed: ₹8,721.17 lakh
  • Changes in Inventories: (₹1,456.48) lakh (decrease)
  • Employee Benefits Expense: ₹1,843.45 lakh
  • Finance Costs: ₹151.51 lakh
  • Depreciation and Amortization: ₹1,083.66 lakh
  • Other Expenses: ₹3,984.17 lakh
  • Profit Before Tax: ₹1,178.87 lakh
  • Tax Expense: ₹286.00 lakh
  • Net Profit for the Period: ₹892.87 lakh
  • Other Comprehensive Income: ₹154.67 lakh
  • Remeasurement gain on defined benefit plans: ₹21.28 lakh
  • Effect of measuring Equity Instruments at Fair Value: ₹161.90 lakh
  • Income tax on above: (₹28.51) lakh
  • Total Comprehensive Income: ₹1,047.54 lakh
  • Earnings Per Share (EPS): Basic and Diluted ₹15.99 each

Comparative Financial Performance (Standalone)

Quarter Ended June 30, 2026 vs June 30, 2025:

  • Net Profit decreased by 33.4% from ₹1,558.07 lakh (Q1 FY26) to ₹892.87 lakh (Q1 FY27)
  • Total Income increased by 1.7% from ₹15,248.35 lakh to ₹15,506.35 lakh
  • Profit Before Tax increased by 33.4% from ₹883.45 lakh to ₹1,178.87 lakh

Year Ended March 31, 2026 (Audited):

  • Net Profit: ₹4,564.81 lakh
  • Total Comprehensive Income: ₹3,329.63 lakh
  • EPS: Basic and Diluted ₹81.73 each

Capital Structure

  • Paid-up Equity Share Capital: ₹558.56 lakh (Face Value ₹10 each)
  • Other Equity: ₹76,187.53 lakh (as of March 31, 2026)

Consolidated Results

Consolidated financial results include the wholly owned subsidiary Transpek Creative Chemistry Private Limited. The consolidated figures for Q1 FY27 are identical to standalone figures, indicating minimal or no separate activity from the subsidiary:

  • Net Profit: ₹892.83 lakh
  • Total Comprehensive Income: ₹1,047.50 lakh
  • EPS: Basic and Diluted ₹15.98 each

Business Segment

The company operates in a single operating segment of "Chemicals" manufacturing as per Ind AS 108.